A detailed history of Vanguard Group Inc transactions in Si Bone, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 2,463,501 shares of SIBN stock, worth $31.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,463,501
Previous 2,419,831 1.8%
Holding current value
$31.9 Million
Previous $50.8 Million 20.6%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$15.15 - $21.58 $661,600 - $942,398
43,670 Added 1.8%
2,463,501 $40.3 Million
Q4 2023

Feb 14, 2024

BUY
$15.75 - $21.38 $1.75 Million - $2.38 Million
111,315 Added 4.82%
2,419,831 $50.8 Million
Q3 2023

Nov 14, 2023

BUY
$20.22 - $27.36 $3.14 Million - $4.24 Million
155,121 Added 7.2%
2,308,516 $49 Million
Q2 2023

Aug 14, 2023

BUY
$19.39 - $28.9 $6.01 Million - $8.95 Million
309,773 Added 16.8%
2,153,395 $58.1 Million
Q1 2023

May 15, 2023

BUY
$12.71 - $21.17 $2.76 Million - $4.59 Million
217,052 Added 13.34%
1,843,622 $36.3 Million
Q4 2022

Feb 10, 2023

BUY
$11.23 - $19.44 $220,860 - $382,326
19,667 Added 1.22%
1,626,570 $22.1 Million
Q3 2022

Nov 14, 2022

BUY
$12.2 - $18.71 $245,427 - $376,389
20,117 Added 1.27%
1,606,903 $28.1 Million
Q2 2022

Aug 12, 2022

BUY
$12.05 - $22.74 $27,064 - $51,074
2,246 Added 0.14%
1,586,786 $20.9 Million
Q1 2022

May 13, 2022

BUY
$18.32 - $23.03 $462,983 - $582,014
25,272 Added 1.62%
1,584,540 $35.8 Million
Q4 2021

Feb 14, 2022

BUY
$18.75 - $24.8 $995,287 - $1.32 Million
53,082 Added 3.52%
1,559,268 $34.6 Million
Q3 2021

Nov 12, 2021

SELL
$19.65 - $31.89 $19,080 - $30,965
-971 Reduced 0.06%
1,506,186 $32.3 Million
Q2 2021

Aug 13, 2021

BUY
$29.4 - $35.96 $44.3 Million - $54.2 Million
1,507,157 New
1,507,157 $47.4 Million

Others Institutions Holding SIBN

About SI-BONE, Inc.


  • Ticker SIBN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 34,305,000
  • Market Cap $444M
  • Description
  • SI-BONE, Inc., a medical device company, develops implantable devices used to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers iFuse, a minimally invasive surgical implant system to address sacroiliac joint dysfunction and degeneration, adult deformity, and pelvic ring traumatic fract...
More about SIBN
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.